secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hoth Therapeutics, Inc. (HOTH)
CIK:        0001711786
Form:       8-K
Filed at:   2022-08-22T23:59:59+00:00
Accession:  0001213900-22-050061
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hoth Therapeutics lowers shareholder meeting quorum to one-third, permits board bylaw changes by written consent
--------------------------------------------------------------------------------

- Board approved amendment reducing quorum for shareholder meetings from majority to one-third of outstanding voting stock.
- Amendment also allows board to adopt, amend, or repeal bylaws by written consent without a meeting.
- Changes made to Article II Section 2.6 and Article X Section 10.1 of Amended and Restated Bylaws.
- Effective as of August 19, 2022; full text filed as Exhibit 3.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711786/000121390022050061/0001213900-22-050061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711786/000121390022050061/ea164742-8k_hoththera.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-050061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer